ZURICH, May 6 (Reuters) - The Swiss government said on
Thursday a U.S. announcement to support waiving intellectual
property rights for COVID-19 vaccines was a significant
announcement but left many questions unanswered.
"This is an important announcement by the U.S., but many
questions remain unanswered about the specific solutions it is
considering in this context," the State Secretariat for Economic
Affairs (SECO) said in an emailed statement.
SECO said Switzerland was still convinced that waiving
intellectual property rights in the context of the pandemic
could not guarantee fair, affordable and rapid access to
vaccines, drugs and diagnostic products against COVID-19.
It said Switzerland would examine this new U.S. request and
its consequences on the Swiss position, with the United States
itself and within the World Trade Organisation.
(Reporting by Silke Koltrowitz;
Editing by Andrew Cawthorne)